FDA, CISA Should Update Medical Device Cybersecurity Agreement: GAO
The Food and Drug Administration-Cybersecurity and Infrastructure Security Agency agreement on cybersecurity guidance for medical device manufacturers and public alerts for current vulnerabilities should be updated to improve agency coordination and clarify roles, the GAO said Thursday. It said the…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
2018 agreement states a goal of sharing information to enhance mutual awareness, heighten coordination, catalyze standards development and enhance technical capabilities between the agencies. GAO said the agreement doesn't reflect developments since it was signed such as FDA's creating a standard operation procedure for sharing information with CISA.